Merck KGaA (FRA:MRKC) Short Interest


FRA:MRKC Merck KGaA FRA:MRKC
81 GF Score
Price €27.60
GF Value €27.71
Valuation Fairly Valued
! 9 Warning Signs
View Full Analysis

What is Merck KGaA Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:MRKC vs ZTS, UTHR, VTRS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Merck KGaA's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Merck KGaA Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck KGaA's Short Interest distribution charts can be found below:

* The bar in red indicates where Merck KGaA's Short Interest falls into.


FRA:MRKC
81GF Score
Merck KGaA FRA:MRKC
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Merck KGaA (FRA:MRKC) Overvalued in 2026?

Based on GuruFocus' analysis, Merck KGaA stock appears to be undervalued. The current stock price of €27.60 is trading 0.4% below its estimated GF Value™ of €27.71. GuruFocus considers Merck KGaA to be Fairly Valued.

Key valuation signals for FRA:MRKC:

  • Short Interest:
  • GF Value™: €27.71 vs. price of €27.60 (0.4% below fair value)
  • GF Score™: 81/100 with 9 warning signs

No single metric tells the full story. See the FRA:MRKC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Merck KGaA Business Description

Address Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293
Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
81GF Score

Get the complete analysis for FRA:MRKC

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€27.60
Price
€27.71
GF Value